Laura Rachele Bettini

6PUBLICATIONS
143CO-AUTHORS
Infant and child healthRegenerative medicine (incl. stem cells)Haematological tumoursInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 28, 2025
First-Line Postremission Blinatumomab as Successful Toxicity-Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia.

Nicolò Peccatori, Benedetta Elena Di Majo, Laura Claut

|Feb 01, 2025
The Role of Candidate Polymorphisms in Drug Transporter Genes on High-Dose Methotrexate in the Consolidation Phase of the AIEOP-BFM ALL 2009 Protocol.

Stefania Braidotti, Giulia Zudeh, Raffaella Franca

|Jun 02, 2022
Potential role of STAG1 mutations in genetic predisposition to childhood hematological malignancies.

Claudia Saitta, Stefano Rebellato, Laura Rachele Bettini

|May 13, 2022
Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase product.

Cristina Matteo, Antonella Colombini, Laura Rachele Bettini

|Sep 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

Paul Bastard, Lindsey B Rosen, Qian Zhang

|Sep 25, 2020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.

Qian Zhang, Paul Bastard, Zhiyong Liu

Pageof 1